Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566) Total Inventories: HK$165 Mil (As of Dec. 2025)


HKSE:02566 Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd HKSE:02566
20 GF Score
Price HK$5.79
! 1 Warning Sign
View Full Analysis

What is Hangzhou Jiuyuan Genetic Biopharmaceutical Co Total Inventories?

Hangzhou Jiuyuan Genetic Biopharmaceutical Co HKSE:02566 -2.03% 20 Total Inventories is HK$165 Mil as of Dec. 2025. GuruFocus rates HKSE:02566 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co's total inventories for the quarter that ended in Dec. 2025 was HK$165 Mil. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's average total inventories from the quarter that ended in Jun. 2025 to the quarter that ended in Dec. 2025 was HK$165 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was HK$3.37.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Days Inventory for the six months ended in Dec. 2025 was 196.92.

Inventory Turnover measures how fast the company turns over its inventory within a year. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Inventory Turnover for the quarter that ended in Dec. 2025 was 0.93.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.22.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co  (HKSE:02566) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is

Net-Net Working Capital Per Share (Q: Dec. 2025 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(789.287+0.75 * 630.862+0.5 * 165.429-518.936
-0-0)/245.399
=3.37

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Days Inventory for the six months ended in Dec. 2025 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2025 )/Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=165.307/153.202*365 / 2
=196.92

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2025 ) / Average Total Inventories (Q: Dec. 2025 )
=153.202 / 165.307
=0.93

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=165.307 / 737.429
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Total Inventories Related Terms

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Total Inventories Historical Data

* Premium members only.

The historical data trend for Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Total Inventories Chart

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Inventories
204.06 158.83 174.84 148.57 165.43

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Inventories Get a 7-Day Free Trial 174.84 159.38 148.57 165.19 165.43
HKSE:02566
20GF Score
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd HKSE:02566
Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of HK$165 Mil mean?
Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566) has a Total Inventories of HK$165 Mil as of Dec. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Hangzhou Jiuyuan Genetic Biopharmaceutical Co and its competitors.
Is Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Total Inventories too high?
Hangzhou Jiuyuan Genetic Biopharmaceutical Co's current Total Inventories is HK$165 Mil. Overall, Hangzhou Jiuyuan Genetic Biopharmaceutical Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Total Inventories compare to VRTX and REGN?
Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Total Inventories of HK$165 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Biotechnology company?
A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Hangzhou Jiuyuan Genetic Biopharmaceutical Co and its competitors. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's current Total Inventories is HK$165 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Jiuyuan Genetic Biopharmaceutical Co stock overvalued right now?
Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566) has a current Total Inventories of HK$165 Mil. The current Total Inventories is HK$165 Mil. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566), the current Total Inventories is HK$165 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Business Description

Address No. 23, Eighth Street, Baiyang Street, Qiantang District, Zhejiang Province, Hangzhou, CHN
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd is a biopharmaceutical company in China. It is engaged in the research & development, manufacturing, and commercialization of biopharmaceutical products and medical devices. The company focuses on four large and fast-growing therapeutic areas: orthopedics, metabolic diseases, oncology, and hematology. Centered around these therapeutic areas, it has built a diversified product portfolio comprising several marketed products, such as Jilifen, Jijufen, Jiouting, Yinuojia, Guyoudao, etc., and has several product candidates under development, such as JY54, JY23, JY47, JY56, JY29-2, etc., targeting various indications. Geographically, the company generates maximum revenue from the Chinese Mainland, and the rest from other countries.
20GF Score

Get the complete analysis for HKSE:02566

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$5.79
Price